Literature DB >> 2730870

Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity.

E M Bevers1, R H Tilly, J M Senden, P Comfurius, R F Zwaal.   

Abstract

Phosphatidylserine (PS) in the plasma membrane of nonactivated human platelets is almost entirely located on the cytoplasmic side. Stimulation of platelets with the Ca2+ ionophore A23187 or combined action of collagen plus thrombin results in a rapid loss of the asymmetric distribution of PS. Also, treatment with the sulfhydryl-reactive compounds diamide and pyridyldithioethylamine (PDA) causes exposure of PS at the platelet outer surface. PS exposure is sensitively measured as the catalytic potential of platelets to enhance the rate of thrombin formation by the enzyme complex factor Xa-factor Va, since this reaction is essentially dependent on the presence of a PS-containing lipid surface. In this paper we demonstrate that endogenous PS, previously exposed at the outer surface during cell activation or sulfhydryl oxidation, can be translocated back to the cytoplasmic leaflet of the membrane by addition of dithiothreitol (DTT) but not by nonpermeable reducing agents like reduced glutathione. Treatment of platelets with trypsin or chymotrypsin, prior to addition of DTT, inhibits the inward transport of exposed PS. Moreover, severe depletion of metabolic ATP, as obtained by platelet stimulation with A23187 in the presence of metabolic inhibitors, though not inhibiting PS exposure at the outer surface, blocks the translocation of endogenous PS to the internal leaflet of the plasma membrane. These results strongly indicate the involvement of a membrane protein in the inward transport of endogenous PS. Recently, an aminophospholipid-specific translocase in the platelet membrane was postulated on the basis of the inward transport of exogenously added PS (analogues) [Sune, A., Bette-Bobillo, P., Bienvenue, A., Fellmann, P., & Devaux, P.F. (1987) Biochemistry 26, 2972-2978].(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730870     DOI: 10.1021/bi00432a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain.

Authors:  Martin P Boland; Claire R Hatty; Frances Separovic; Andrew F Hill; Deborah J Tew; Kevin J Barnham; Cathryn L Haigh; Michael James; Colin L Masters; Steven J Collins
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

Review 3.  Transmembrane movements of lipids.

Authors:  A Zachowski; P F Devaux
Journal:  Experientia       Date:  1990-06-15

4.  Effective bilayer expansion and erythrocyte shape change induced by monopalmitoyl phosphatidylcholine. Quantitative light microscopy and nuclear magnetic resonance spectroscopy measurements.

Authors:  L M Chi; W G Wu
Journal:  Biophys J       Date:  1990-06       Impact factor: 4.033

Review 5.  Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement.

Authors:  A Zachowski
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

6.  Involvement of the Na+/H+ exchanger in membrane phosphatidylserine exposure during human platelet activation.

Authors:  Robert Bucki; Jennifer J Pastore; Françoise Giraud; Paul A Janmey; Jean-Claude Sulpice
Journal:  Biochim Biophys Acta       Date:  2006-01-17

7.  Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds.

Authors:  C A Goodwin; C P Wheeler-Jones; S Namiranian; S Bokkala; V V Kakkar; K S Authi; M F Scully
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

8.  Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Authors:  Matthew P Kosloski; Krithika A Shetty; Hironao Wakabayashi; Philip J Fay; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2014-06-17       Impact factor: 4.009

Review 9.  TRAIL gene therapy: from preclinical development to clinical application.

Authors:  Thomas S Griffith; Brittany Stokes; Tamara A Kucaba; James K Earel; Rebecca L VanOosten; Erik L Brincks; Lyse A Norian
Journal:  Curr Gene Ther       Date:  2009-02       Impact factor: 4.391

10.  Enhancement of thrombin-thrombomodulin-catalysed protein C activation by phosphatidylethanolamine containing unsaturated fatty acids: possible physiological significance of phosphatidylethanolamine in anticoagulant activity of thrombomodulin.

Authors:  S Horie; H Ishii; H Hara; M Kazama
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.